PRORICH
Live / Registered — Registered (as of 16 Jul 2024)
What this means for you
Registered since 16 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97034494
- Registration number
- 7451234
- Mark type
- Stylized text
- Filed
- 18 Sept 2021
- Published for opposition
- 02 Aug 2022
- Registered
- 16 Jul 2024
- Attorney of record
- He Li
Goods and services
- Class 001 — Chemicals: Chemical reagents for non-medical purposes; Chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis or labeling of nucleic acid; Laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Nucleic acid isolation and purification kit consisting primarily of reagents and magnetic beads for scientific research purposes; Reagents for use in scientific apparatus for chemical or biological analysis
- Class 005 — Pharmaceuticals: Chemical reagents for medical or veterinary purposes; Diagnostic biomarker reagents for medical purposes
Owner
- Prorich medical corporation, New Taipei City, TW
- Prorich medical corporation, New Taipei City, TW
- Prorich medical corporation, New Taipei City, TW
Prosecution history
- 16 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 16 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 11 Jun 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Jun 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 15 May 2024 — STATEMENT OF USE PROCESSING COMPLETE
- 18 Apr 2024 — USE AMENDMENT FILED
- 14 May 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 18 Apr 2024 — TEAS STATEMENT OF USE RECEIVED
- 29 Mar 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Mar 2024 — SOU EXTENSION 3 GRANTED
- 27 Mar 2024 — SOU EXTENSION 3 FILED
- 27 Mar 2024 — SOU TEAS EXTENSION RECEIVED
- 21 Sept 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Sept 2023 — SOU EXTENSION 2 GRANTED